METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
R García-Vílchez, AM Añazco-Guenkova, S Dietmann… - Molecular cancer, 2023 - Springer
Newly growing evidence highlights the essential role that epitranscriptomic marks play in the
development of many cancers; however, little is known about the role and implications of …
development of many cancers; however, little is known about the role and implications of …
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
The emerging" epitranscriptomics" field is providing insights into the biological and
pathological roles of different RNA modifications. The RNA methyltransferase METTL1 …
pathological roles of different RNA modifications. The RNA methyltransferase METTL1 …
METTL6 is a tRNA m3C methyltransferase that regulates pluripotency and tumor cell growth
Recently, covalent modifications of RNA, such as methylation, have emerged as key
regulators of all aspects of RNA biology and have been implicated in numerous diseases …
regulators of all aspects of RNA biology and have been implicated in numerous diseases …
METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development
X Ying, B Liu, Z Yuan, Y Huang, C Chen… - Clinical and …, 2021 - Wiley Online Library
Background The posttranscriptional modifications of transfer RNA (tRNA) are critical for all
aspects of the tRNA function and have been implicated in the tumourigenesis and …
aspects of the tRNA function and have been implicated in the tumourigenesis and …
METTL1 promotes hepatocarcinogenesis via m7G tRNA modification‐dependent translation control
Z Chen, W Zhu, S Zhu, K Sun, J Liao… - Clinical and …, 2021 - Wiley Online Library
Abstract Background N7‐methylguanosine (m7G) modification is one of the most common
transfer RNA (tRNA) modifications in humans. The precise function and molecular …
transfer RNA (tRNA) modifications in humans. The precise function and molecular …
N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression
Z Dai, H Liu, J Liao, C Huang, X Ren, W Zhu, S Zhu… - Molecular cell, 2021 - cell.com
Cancer cells selectively promote translation of specific oncogenic transcripts to facilitate
cancer survival and progression, but the underlying mechanisms are poorly understood …
cancer survival and progression, but the underlying mechanisms are poorly understood …
[HTML][HTML] Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells
Y Chen, C Pan, X Wang, D Xu, Y Ma, J Hu, P Chen… - Theranostics, 2021 - ncbi.nlm.nih.gov
Background: Since primary prostate cancer (PCa) can advance to the life-threatening
metastatic PCa, exploring the molecular mechanisms underlying PCa metastasis is crucial …
metastatic PCa, exploring the molecular mechanisms underlying PCa metastasis is crucial …
METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8-mediated neutrophil infiltration
J He, M Zhou, J Yin, J Wan, J Chu, J Jia, J Sheng… - Molecular Therapy, 2021 - cell.com
Growing evidence indicates that N6-methyladenosine (m 6 A) is the most pervasive RNA
modification in eukaryotic cells. However, the specific role of METTL3 in papillary thyroid …
modification in eukaryotic cells. However, the specific role of METTL3 in papillary thyroid …
METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis
X Wei, Y Huo, J Pi, Y Gao, S Rao, M He, Q Wei… - Nature cell …, 2022 - nature.com
METTL3 encodes the predominant catalytic enzyme to promote m6A methylation in nucleus.
Recently, accumulating evidence has shown the expression of METTL3 in cytoplasm, but its …
Recently, accumulating evidence has shown the expression of METTL3 in cytoplasm, but its …
N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is
characterized by high recurrence and heterogeneity, yet its mechanism is not well …
characterized by high recurrence and heterogeneity, yet its mechanism is not well …